TY - JOUR
T1 - Human papillomavirus type 45 propagation, infection, and neutralization
AU - McLaughlin-Drubin, Margaret E.
AU - Wilson, Susan
AU - Mullikin, Brian
AU - Suzich, Jo Ann
AU - Meyers, Craig
N1 - Funding Information:
We thank the members of the Meyers laboratory for many helpful discussions, Dr. Attila Lorincz for providing the HPV45 clone, and Lyn Budgeon for histological assistance. This work was supported by an industry university research contract from MedImmune, Inc. (Gaithersberg, MD).
PY - 2003/7/20
Y1 - 2003/7/20
N2 - The organotypic (raft) culture system has allowed the study of the entire differentiation-dependent life cycle of human papillomaviruses (HPVs), including virion morphogenesis. We introduced linearized HPV45 genomic DNA into primary keratinocytes, where it recircularized and maintained episomally at a range of 10-50 copies of HPV genomic DNA. Following epithelial stratification and differentiation in organotypic culture, virion morphogenesis occurred. HPV45 virions were purified from raft cultures and were able to infect keratinocytes in vitro. By testing a panel of HPV VLP antisera, we were able to demonstrate that the infection was neutralized not only with human HPV45 VLP-specific antiserum, but also with human HPV18 VLP-specific antiserum, demonstrating serological cross-reactivity between HPV18 and HPV45.
AB - The organotypic (raft) culture system has allowed the study of the entire differentiation-dependent life cycle of human papillomaviruses (HPVs), including virion morphogenesis. We introduced linearized HPV45 genomic DNA into primary keratinocytes, where it recircularized and maintained episomally at a range of 10-50 copies of HPV genomic DNA. Following epithelial stratification and differentiation in organotypic culture, virion morphogenesis occurred. HPV45 virions were purified from raft cultures and were able to infect keratinocytes in vitro. By testing a panel of HPV VLP antisera, we were able to demonstrate that the infection was neutralized not only with human HPV45 VLP-specific antiserum, but also with human HPV18 VLP-specific antiserum, demonstrating serological cross-reactivity between HPV18 and HPV45.
UR - http://www.scopus.com/inward/record.url?scp=0043169726&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0043169726&partnerID=8YFLogxK
U2 - 10.1016/S0042-6822(03)00312-X
DO - 10.1016/S0042-6822(03)00312-X
M3 - Article
C2 - 12890615
AN - SCOPUS:0043169726
SN - 0042-6822
VL - 312
SP - 1
EP - 7
JO - Virology
JF - Virology
IS - 1
ER -